Treatment of mitral & tricuspid regurgitation – what you need to know | 2021 ESC guidelines update

preview_player
Показать описание
Drs José Luis Zamorano, Marco Metra and Bernard Prendergast discuss the latest advancements in heart failure patients with reduced ejection fraction and take questions on the release of the 2021 ESC guidelines related to the treatment of mitral and tricuspid regurgitation patients.

Agenda:
2:07 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Primary MR and Secondary MR (Marco Metra, Brescia, Italy)
9:30 Questions from the floor (José Luis Zamorano, Madrid, Spain; Bernard Prendergast, London, UK; Marco Metra, Brescia, Italy)
19:11 ESC-HF Guidelines Tricuspid Regurgitation (Bernard Prendergast, London, UK)
21:07 Recap and discussion (José Luis Zamorano, Madrid, Spain; Bernard Prendergast, London, UK; Marco Metra, Brescia, Italy)

Content related to Edwards Lifesciences devices is intended for healthcare professionals. By viewing, you confirm you are a healthcare professional. The contents herein are intended for viewers in Europe excluding France.
Рекомендации по теме